Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group..

Hypertens Res. 2016 Dec 1. doi: 10.1038/hr.2016.158. [Epub ahead of print]

PMID:
27904156
2.

Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study.

Hidese S, Ota M, Wakabayashi C, Noda T, Ozawa H, Okubo T, Kunugi H.

Acta Neuropsychiatr. 2016 Jul 11:1-8. [Epub ahead of print]

PMID:
27396868
3.

Antihelminthic potential of quinacrine and oxyclozanide against gill parasite Microcotyle sebastis in black rockfish Sebastes schlegeli.

Kang YJ, Wakabayashi C, Kim KH.

Dis Aquat Organ. 2016 May 26;119(3):259-63. doi: 10.3354/dao02997.

PMID:
27225210
4.

Recreational drug use and related social factors among HIV-positive men in Japan.

Togari T, Inoue Y, Takaku Y, Abe S, Hosokawa R, Itagaki T, Yoshizawa S, Oki S, Katakura N, Yamauchi A, Wakabayashi C, Yajima T.

AIDS Care. 2016 Jul;28(7):932-40. doi: 10.1080/09540121.2016.1140888.

PMID:
26887351
5.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group..

Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104.

6.

Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.

Wakabayashi C, Numakawa T, Ooshima Y, Hattori K, Kunugi H.

Psychopharmacology (Berl). 2015 Dec;232(24):4393-400. doi: 10.1007/s00213-015-4068-x.

PMID:
26359228
7.

IL-1 receptor-antagonist (IL-1Ra) knockout mice show anxiety-like behavior by aging.

Wakabayashi C, Numakawa T, Odaka H, Ooshima Y, Kiyama Y, Manabe T, Kunugi H, Iwakura Y.

Neurosci Lett. 2015 Jul 10;599:20-5. doi: 10.1016/j.neulet.2015.05.019.

PMID:
26002078
8.

Effect of L-theanine on glutamatergic function in patients with schizophrenia.

Ota M, Wakabayashi C, Sato N, Hori H, Hattori K, Teraishi T, Ozawa H, Okubo T, Kunugi H.

Acta Neuropsychiatr. 2015 Oct;27(5):291-6. doi: 10.1017/neu.2015.22.

PMID:
25896423
9.

Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.

Ota M, Ogawa S, Kato K, Wakabayashi C, Kunugi H.

Psychiatry Res. 2015 Apr 30;232(1):92-7. doi: 10.1016/j.pscychresns.2015.01.023.

PMID:
25703679
10.

Chemomechanical coupling of human mitochondrial F1-ATPase motor.

Suzuki T, Tanaka K, Wakabayashi C, Saita E, Yoshida M.

Nat Chem Biol. 2014 Nov;10(11):930-6. doi: 10.1038/nchembio.1635.

PMID:
25242551
11.

Effect of L-theanine on sensorimotor gating in healthy human subjects.

Ota M, Wakabayashi C, Matsuo J, Kinoshita Y, Hori H, Hattori K, Sasayama D, Teraishi T, Obu S, Ozawa H, Kunugi H.

Psychiatry Clin Neurosci. 2014 May;68(5):337-43. doi: 10.1111/pcn.12134.

12.

Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.

Okada S, Morimoto T, Ogawa H, Sakuma M, Soejima H, Nakayama M, Sugiyama S, Jinnouchi H, Waki M, Doi N, Horii M, Kawata H, Somekawa S, Soeda T, Uemura S, Saito Y; investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial..

Circ J. 2013;77(12):3023-8.

13.

Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.

Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group..

Hypertens Res. 2013 Nov;36(11):947-58. doi: 10.1038/hr.2013.63.

PMID:
23864054
14.

Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.

Soejima H, Ogawa H, Morimoto T, Nakayama M, Okada S, Sakuma M, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators..

J Cardiol. 2013 Sep;62(3):165-70. doi: 10.1016/j.jjcc.2013.03.015.

15.

Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.

Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T.

J Immunol. 2013 Jun 1;190(11):5436-45. doi: 10.4049/jimmunol.1203576.

16.

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, Kunugi H.

J Psychiatr Res. 2013 Mar;47(3):401-6. doi: 10.1016/j.jpsychires.2012.12.001.

PMID:
23290488
17.

Effect of stamped reply envelopes and timing of newsletter delivery on response rates of mail survey: a randomised controlled trial in a prospective cohort study.

Wakabayashi C, Hayashi K, Nagai K, Sakamoto N, Iwasaki Y.

BMJ Open. 2012 Sep 4;2(5). pii: e001181. doi: 10.1136/bmjopen-2012-001181.

18.

Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex.

Chiba S, Numakawa T, Ninomiya M, Richards MC, Wakabayashi C, Kunugi H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):112-9. doi: 10.1016/j.pnpbp.2012.05.018.

PMID:
22664354
19.

Behavioral and molecular evidence for psychotropic effects in L-theanine.

Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H.

Psychopharmacology (Berl). 2012 Feb;219(4):1099-109. doi: 10.1007/s00213-011-2440-z.

PMID:
21861094
20.

Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor α₁A subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice.

Wakabayashi C, Kiyama Y, Kunugi H, Manabe T, Iwakura Y.

Neuroscience. 2011 Sep 29;192:475-84. doi: 10.1016/j.neuroscience.2011.06.031.

PMID:
21722710
Items per page

Supplemental Content

Loading ...
Support Center